Effect of rosuvastatin on plasma coenzyme Q10 in HIV-infected individuals on antiretroviral therapy

References

• Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation. 2004;110:227–239.10.1161/01.CIR.0000133317.49796.0E
   PubMed Web of Science ®Google Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the ACC/AHA task force on practice guidelines. Circulation. 2014;129:S1–S45.10.1161/01.cir.0000437738.63853.7a
   PubMed Web of Science ®Google Scholar
• Mabuchi H, Higashikata T, Kawashiri M, et al. Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients. J Athero Thromb. 2005;12:111–119.10.5551/jat.12.111
   PubMed Web of Science ®Google Scholar
• Rundek T, Naini A, Sacco R, Coates K, DiMauro S. Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. Arch Neurol. 2004;61:889–892.10.1001/archneur.61.6.889
   PubMed Web of Science ®Google Scholar
• Suzuki T, Nozawa T, Sobajima M, et al. Atorvastatin-induced changes in plasma coenzyme Q10 and brain natriuretic peptide in patients with coronary artery disease. Int Heart J. 2008;49(4):423–433.10.1536/ihj.49.423
   PubMed Web of Science ®Google Scholar
• Berthold H, Naini A, Di Mauro S, et al. Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma. Drug Saf. 2006;29(8):703–712.10.2165/00002018-200629080-00007
   PubMed Web of Science ®Google Scholar
• Bleske BE, Willis RA, Anthony M, et al. The effect of pravastatin and atorvastatin on coenzyme Q10. Am Heart J. 2001;142(2):e2–e7.
   PubMedGoogle Scholar
• Mortensen SA, Leth A, Agner E, Rohde M. Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors. Mol Aspects Med. 1997;18:s137–s144.10.1016/S0098-2997(97)00014-9
   PubMed Web of Science ®Google Scholar
• Littarru GP, Langsjoen P. Coenzyme Q10 and statins: biochemical and clinical implications. Mitochondrion. 2007;7:s168–s174.10.1016/j.mito.2007.03.002
   PubMed Web of Science ®Google Scholar
• Caso G, Kelly P, McNurlan MA, Lawson WE. Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins. Am J Cardiol. 2007;99:1409–1412.10.1016/j.amjcard.2006.12.063
   PubMed Web of Science ®Google Scholar
• Crane FL. Discovery of ubiquinone (coenzyme Q) and an overview of function. Mitochondrion. 2007;7:s2–s7.10.1016/j.mito.2007.02.011
   PubMed Web of Science ®Google Scholar
• Bentinger M, Brismar K, Dallner G. The antioxidant role of coenzyme Q. Mitochondrion. 2007;7:s41–s50.10.1016/j.mito.2007.02.006
   PubMed Web of Science ®Google Scholar
• Marcoff L, Thompson PD. The role of coenzyme Q10 in statin associated myopathy: a systematic review. J Am Coll Cardiol. 2007;49:2231–2237.10.1016/j.jacc.2007.02.049
   PubMed Web of Science ®Google Scholar
• Lamperti C, Naini AB, Lucchini V. Muscle coenzyme Q10 level in statin-related myopathy. Arch Neurol. 2005;62:1709–1712.10.1001/archneur.62.11.1709
   PubMed Web of Science ®Google Scholar
• Keith M, Mazer CD, Mikhail P, Jeejeebhoy F, Briet F, Errett L. Coenzyme Q10 in patients undergoing CABG: effect of statins and nutritional supplementation. Nutr Metab Cardiovasc Dis. 2008;18(2):105–111.10.1016/j.numecd.2006.09.011
   PubMed Web of Science ®Google Scholar
• Young JM, Florkowski CM, Molyneux SL, et al. Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia. Am J Cardiol. 2007;100:1400–1403.10.1016/j.amjcard.2007.06.030
   PubMed Web of Science ®Google Scholar
• Bookstaver DA, Burkhalter NA, Hatzigeorgiou C. Effect of coenzyme Q10 supplementation on statin-induced myalgias. Am J Cardiol. 2012;110:526–529.10.1016/j.amjcard.2012.04.026
   PubMed Web of Science ®Google Scholar
• Mabuchi H, Nohara A, Kobayashi J, Kawashiri M, Katsuda S, Inazu A. Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study. Atherosclerosis. 2007;195(2):e182–e189.10.1016/j.atherosclerosis.2007.06.010
   PubMed Web of Science ®Google Scholar
• Lee B, Huang Y, Chen S, Lin P. Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease. Nutrition. 2012;28:767–772.10.1016/j.nut.2011.11.008
   PubMed Web of Science ®Google Scholar
• Gökbel H, Gergerlioğlu HS, Okudan N, Gül İbrahim, Büyükbaş S, Belviranlı M. Effects of coenzyme Q10 supplementation on plasma adiponectin, interleukin-6, and tumor necrosis factor- α levels in men. J Med Food. 2010;13(1):216–218.10.1089/jmf.2008.0310
   PubMed Web of Science ®Google Scholar
• Bessler H, Bergman M, Blumberger N, Djaldetti M, Salman H. Coenzyme Q10 decreases TNF-α and IL-2 secretion by human peripheral blood mononuclear cells. J Nutr Sci Vitaminol. 2010;56:77–81.
   PubMed Web of Science ®Google Scholar
• Sanoobar M, Eghtesadi S, Azimi A, et al. Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial. Nutr Neurosci. 2015;18(4):169–176.10.1179/1476830513Y.0000000106
   PubMed Web of Science ®Google Scholar
• Rogers JK, Jhund PS, Perez AC, et al. Effect of rosuvastatin on repeat heart failure: the CORONA trial. JACC Heart Fail. 2014;2(3):289–297.10.1016/j.jchf.2013.12.007
   PubMed Web of Science ®Google Scholar
• Molyneux SL, Florkowski CM, George PM, et al. Coenzyme Q10: an independent predictor of mortality in chronic heart failure. J Am Coll Cardiol. 2008;52(18):1435–1441.10.1016/j.jacc.2008.07.044
   PubMed Web of Science ®Google Scholar
• Mortensen SA, Vadhanavikit S, Folkers K. Deficiency of coenzyme Q10 in myocardial failure. Drugs Under Exp Clin Res. 1984;7:497–502.
   Google Scholar
• Gao L, Mao Q, Cao J, Wang Y, Zhou X. Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials. Atherosclerosis. 2012;221:311–316.10.1016/j.atherosclerosis.2011.10.027
   PubMed Web of Science ®Google Scholar
• Longenecker CT, Triant VA. Initiation of antiretroviral therapy at high CD4 counts: does it reduce the risk of cardiovascular disease. Curr Opin HIV AIDS. 2014;9(1):54–62.10.1097/COH.0000000000000015
   PubMed Web of Science ®Google Scholar
• Folkers K, Langsjoen P, Nara Y, et al. Biochemical deficiencies of coenzyme Q10 in HIV-infection and exploratory treatment. Biochem and Biophys Res Comm. 1988;153(2):888–896.10.1016/S0006-291X(88)81179-3
   PubMed Web of Science ®Google Scholar
• Folkers K, Hanioka T, Xia LJ, McRee JT, Langsjoen P. Coenzyme Q10 increases T4/T8 ratios of lymphocytes in ordinary subjects and relevance to patients having the aids related complex. Biochem Biophys Res Commun. 1991;176(2):786–791.10.1016/S0006-291X(05)80254-2
   PubMed Web of Science ®Google Scholar
• Folkers K, Morita M, Mcree J. The activities of coenzyme Q10 and vitamin B6 for immune responses. Biochem Biophys Res Commun. 1993;193(1):88–92.10.1006/bbrc.1993.1593
   PubMed Web of Science ®Google Scholar
• Cherry CL, Mobarok M, Wesselingh SL, et al. Ubisol-Aqua™: coenzyme Q10 prevents antiretroviral toxic neuropathy in an in vitro model. Current HIV Res. 2010;8:232–239.10.2174/157016210791111106
   PubMed Web of Science ®Google Scholar
• Xue SY, Hebert VY, Hayes DM, Robinson CN, Glover M, Dugas TR. Nucleoside reverse transcriptase inhibitors induce a mitophagy-associated endothelial cytotoxicity that is reversed by coenzyme Q10 cotreatment. Toxicol. Sci. 2013;134(2):323–334.10.1093/toxsci/kft105
   PubMed Web of Science ®Google Scholar
• Longenecker CT, Hileman CO, Funderburg NT, McComsey GA. Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial. Clin Infect Dis. 2014;59(8):1148–1156.10.1093/cid/ciu523
   PubMed Web of Science ®Google Scholar
• Funderburg NT, Jiang Y, Debanne SM, et al. Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy. J Acquir Immune Defic Syndr. 2015;68(4):396.10.1097/QAI.0000000000000478
   PubMed Web of Science ®Google Scholar
• Kaplan RC, Sinclair E, Landay AL, et al. T cell activation predicts carotid artery stiffness among HIV-infected women. Atherosclerosis. 2011;217:207–213.10.1016/j.atherosclerosis.2011.03.011
   PubMed Web of Science ®Google Scholar
• Seaberg EC, Benning L, Sharrett AR, et al. Association between human immunodeficiency virus infection and stiffness of the common carotid artery. Stroke. 2010;41:2163–2170.10.1161/STROKEAHA.110.583856
   PubMed Web of Science ®Google Scholar
• Eckard AR, Jiang Y, Debanne SM, Funderburg NT, McComsey GA. Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy. J Infect Dis. 2014;209(8):1156–1164.10.1093/infdis/jiu012
   PubMed Web of Science ®Google Scholar
• Funderburg NT, Jiang Y, Debanne SM, et al. Rosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapy. Clin Infect Dis. 2014;58(4):588–595.10.1093/cid/cit748
   PubMed Web of Science ®Google Scholar
• Liu CS, Lii CK, Chang LL, et al. Atorvastatin increases blood ratios of vitamin E/low-density lipoprotein cholesterol and coenzyme Q10/low-density lipoprotein cholesterol in hypercholesterolemic patients. Nutr Res. 2010;30:118–124.10.1016/j.nutres.2010.01.007
   PubMed Web of Science ®Google Scholar
• Adams SP, Sekhon SS, Wright JM. Lipid-lowering efficacy of rosuvastatin. Cochrane Database Syst Rev. 2014;11: epub. doi: 10.1002/14651858.CD010254.pub2
   Web of Science ®Google Scholar
• Tousoulis D, Psarros C, Demosthenous M, Patel R, Antoniades C, Stefanadis C. Innate and adaptive inflammation as a therapeutic target in vascular disease. J Am Coll Cardiol. 2014;63(23):2491–2502.10.1016/j.jacc.2014.01.054
   PubMed Web of Science ®Google Scholar
• Lee J, Hong YS, Jeong JH, et al. Coenzyme Q10 ameliorates pain and cartilage degradation in a rat model of osteoarthritis by regulating nitric oxide and inflammatory cytokines. PLoS ONE. 2013;8(7):e69362–69369.10.1371/journal.pone.0069362
   PubMed Web of Science ®Google Scholar
• El Morsy EM, Kamel R, Ahmed MA. Attenuating effects of coenzyme Q10 and amlodipine in ulcerative colitis model in rats. Immunopharmacol immunotoxicol. 2015;37(3):244–251, epub.
   PubMed Web of Science ®Google Scholar
• McMurray JJ, Dunselman P, Wedel H, et al. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure. J Am Coll Cardiol. 2010;56(15):1196–1204.10.1016/j.jacc.2010.02.075
   PubMed Web of Science ®Google Scholar
• Toyama K, Sugiyama S, Oka H, et al. Rosuvastatin combined with regular exercise preserves coenzyme Q10 levels associated with a significant increase in high-density lipoprotein cholesterol in patients with coronary artery disease. Atherosclerosis. 2011;217:158–164.10.1016/j.atherosclerosis.2011.02.050
   PubMed Web of Science ®Google Scholar